Home › Funds › Siren, L.L.C. › SRRK
Siren, L.L.C. position in SRRK
Scholar Rock Holding Corporation · Health Care
Siren, L.L.C. reported holding 9,375,013 shares of SRRK (Scholar Rock Holding Corporation) in its Q3 2026 13F filing — a position valued at US$453.0M, representing 10.76% of its reported portfolio and ranking #1 among its reported holdings. Siren, L.L.C. has disclosed SRRK holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Siren, L.L.C.'s SRRK position evolved
Siren, L.L.C. first disclosed a stake in SRRK in Q3 2024 at 11,259,438 shares (US$90.2M). The position peaked in Q1 2026 at 10,825,013 shares, worth US$532.2M. Across 9 filings, Siren, L.L.C. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 9,375,013 shares valued at US$453.0M — a reduction of -200,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 11.26M | $90.19M | New |
| Q4 2024 | 9.25M | $399.79M | Reduce |
| Q1 2025 | 9.25M | $297.39M | Hold |
| Q2 2025 | 9.25M | $327.64M | Hold |
| Q3 2025 | 9.25M | $344.47M | Hold |
| Q4 2025 | 10.83M | $476.84M | Add |
| Q1 2026 | 10.83M | $532.16M | Hold |
| Q2 2026 | 9.58M | $526.63M | Reduce |
| Q3 2026 | 9.38M | $453.00M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRRK and 13F data
SRRK (Scholar Rock Holding Corporation) is a Health Care company. 52 other funds we track also report a position in SRRK — the largest reported positions include Samsara BioCapital, LLC (US$379.4M), Orbis Allan Gray Ltd (US$326.3M), Redmile Group, LLC (US$237.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRRK
- Samsara BioCapital, LLC 6.90M sh · $379.37M · Q2 2026
- Orbis Allan Gray Ltd 5.93M sh · $326.34M · Q2 2026
- Redmile Group, LLC 4.31M sh · $237.11M · Q2 2026
- Bellevue Group AG 2.45M sh · $134.73M · Q2 2026
- Hood River Capital Management LLC 2.22M sh · $122.36M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 2.21M sh · $121.31M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 2.11M sh · $116.13M · Q2 2026
- Integral Health Asset Management, LLC 750.00K sh · $41.25M · Q2 2026
- Rock Springs Capital Management LP 715.45K sh · $39.35M · Q2 2026
- Casdin Capital 665.00K sh · $36.58M · Q2 2026
- Eagle Health Investments LP 555.27K sh · $30.54M · Q2 2026
FAQ
How long has Siren, L.L.C. held SRRK?
Siren, L.L.C. has disclosed SRRK holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Siren, L.L.C.'s current position in SRRK?
As of Q3 2026, Siren, L.L.C. holds 9.38M shares of SRRK (Scholar Rock Holding Corporation), valued at $453.00M, representing 10.76% of its reported portfolio and ranking #1.
Has Siren, L.L.C. been buying or selling SRRK?
In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in SRRK. The position peaked in Q1 2026 at 10.83M shares.
Which other funds hold SRRK?
Other major institutional holders of SRRK include Samsara BioCapital, LLC, Orbis Allan Gray Ltd, Redmile Group, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.